10.1111/ced.14699
Journal article
2021-10-01T00:00:00+00:00
46
1373 - 1375
2
Humans, Immunologic Factors, Male, Middle Aged, Multiple Sclerosis, Relapsing-Remitting, Natalizumab, Pruritus, Skin, Skin Diseases